|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
c.1567T>G |
1686T>G |
p.L523V |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.036975239 |
1.033092037 |
- |
1.071290862 |
- |
BRCA1_00245 |
11 |
c.1571C>T |
1690C>T |
p.A524G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.713611535 |
1.067279157 |
- |
0.761622718 |
- |
BRCA1_00600 |
11 |
c.1601A>G |
1720A>G |
p.Q534R |
0.005311302 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.237297322 |
1.102597599 |
- |
0.261643458 |
- |
BRCA1_00605 |
11 |
c.1616C>T |
1735C>T |
p.T539M |
0.000272547 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.05402426 |
0.3476 |
0.450962699 |
1.577415842 |
- |
0.01335843 |
- |
BRCA1_00248 |
11 |
c.1642A>G |
1761A>G |
p.I548V |
0.051954465 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
2.599266094 |
1.033092037 |
- |
2.685281104 |
- |
BRCA1_00249 |
11 |
c.1648A>C |
1767A>C |
p.N550H |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Spurdle et al. 2008 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.0007 |
0.143 |
- |
0.0000008 |
- |
8.00800E-11 |
- |
BRCA1_00033 |
11 |
c.1703C>G |
1822C>G |
p.P568R |
0.001752635 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.21 |
0.383841549 |
1.067279157 |
- |
0.086029878 |
- |
BRCA1_00250 |
11 |
c.1703C>T |
1822C>T |
p.P568L |
8.19421E-06 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.0395 |
0.01539 |
0.418721101 |
1.577415842 |
- |
0.00040152 |
- |
BRCA1_00251 |
11 |
c.1733C>A |
1852C>A |
p.S578Y |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.700020165 |
1.033092037 |
- |
0.723185258 |
- |
BRCA1_00254 |
11 |
c.1745C>T |
1864C>T |
p.T582M |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.033092037 |
- |
0.805513149 |
- |
BRCA1_00255 |
11 |
c.1756C>T |
1875C>T |
p.P586S |
0.004739851 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.225883846 |
1.033092037 |
- |
0.233358803 |
- |
BRCA1_00256 |
11 |
c.1766G>T |
1885G>T |
p.S589I |
0.050387597 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
2.6 |
- |
- |
- |
2.6 |
- |
BRCA1_00257 |
11 |
c.1768A>G |
1887A>G |
p.S590G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.537780316 |
1.033092037 |
- |
1.5886686 |
- |
BRCA1_00258 |
11 |
c.1772T>C |
1891T>C |
p.I591T |
0.002868568 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.123752175 |
1.1390848 |
- |
0.140964222 |
- |
BRCA1_00259 |
11 |
c.1786C>G |
1905C>G |
p.L596V |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.9986 |
0.4 |
1.27958483 |
1.033092037 |
- |
0.528031279 |
- |
BRCA1_00260 |
11 |
c.1789G>A |
1908G>A |
p.E597K |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
2.82E-07 |
0.01202 |
- |
3.38964E-9 |
- |
BRCA1_00064 |
11 |
c.1824_1826del |
1943del3 |
p.K608del |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
1.9083 |
0.4 |
1.064966292 |
1.033092037 |
- |
0.83981092 |
- |
BRCA1_00262 |
11 |
c.1834A>G |
1953A>G |
p.R612G |
0.000492152 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.34 |
0.066489318 |
1.067279157 |
- |
0.024127306 |
- |
BRCA1_00263 |
11 |
c.1846_1848del |
1965del3 |
p.S616del |
5.40107E-06 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.00112896 |
1.730290135 |
0.135481723 |
- |
0.000264654 |
- |
BRCA1_00264 |
11 |
c.1865C>G |
1984C>G |
p.A622G |
0.070587835 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
3.602289204 |
1.033092037 |
- |
3.721496293 |
- |
BRCA1_00265 |
11 |
c.1865C>T |
1984C>T |
p.A622V |
0.00002 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.00037 |
2.82 |
- |
0.00104 |
- |
BRCA1_00065 |
11 |
c.1879G>A |
1998G>A |
p.V627I |
0.004336792 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.193568727 |
1.102597599 |
- |
0.213428413 |
- |
BRCA1_00266 |
11 |
c.1897C>T |
2016C>T |
p.P633S |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.458278208 |
1.102597599 |
- |
0.505296452 |
- |
BRCA1_00267 |
11 |
c.1903A>G |
2022A>G |
p.N635D |
0.007934592 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.379351112 |
1.033092037 |
- |
0.391904613 |
- |
BRCA1_00268 |
11 |
c.1912G>A |
2031G>A |
p.E638K |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.033092037 |
- |
0.805513149 |
- |
BRCA1_00270 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
11 |
c.1924G>C |
2043G>C |
p.D642H |
0.00001 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.00324 |
- |
0.178 |
1.17 |
- |
0.00067 |
- |
BRCA1_00066 |
11 |
c.1927A>G |
2046A>G |
p.S643G |
0.000549605 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.0625 |
- |
0.417317436 |
1.033092037 |
- |
0.026945458 |
- |
BRCA1_00630 |
11 |
c.1960A>C (Reported 2 times) |
2079A>C |
p.K654Q |
0.00686 |
2 - Likely not pathogenic or of little clinical significance |
Osorio et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
0.9675 |
0.35 |
- |
- |
0.33863 |
- |
BRCA1_00106 |
11 |
c.1984_1992del |
2103del9 |
p.H662_R664del |
0.060582822 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
3.16 |
- |
- |
- |
3.16 |
- |
BRCA1_00275 |
11 |
c.1995C>A |
2114C>A |
p.N665K |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.844299087 |
1.033092037 |
- |
1.905330701 |
- |
BRCA1_00276 |
11 |
c.2002C>T |
2121C>T |
p.L668F |
0.00019 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1.26 |
- |
0.00141 |
5.37 |
- |
0.00954 |
- |
BRCA1_00067 |
11 |
c.2006T>C |
2125T>C |
p.M669T |
0.001931494 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.083247838 |
1.1390848 |
- |
0.094826347 |
- |
BRCA1_00280 |
11 |
c.2014A>G |
2133A>G |
p.K672E |
0.008097166 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.4 |
- |
- |
- |
0.4 |
- |
BRCA1_00281 |
11 |
c.2042G>T |
2161G>T |
p.S681I |
0.008027761 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.383841549 |
1.033092037 |
- |
0.396543648 |
- |
BRCA1_00283 |
11 |
c.2050C>T |
2169C>T |
p.P684S |
0.001493907 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.066489318 |
1.102597599 |
- |
0.073310963 |
- |
BRCA1_00284 |
11 |
c.2060A>C |
2179A>C |
p.Q687P |
0.00672794 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.31097962 |
1.067279157 |
- |
0.331902067 |
- |
BRCA1_00285 |
11 |
c.2077G>A |
2196G>A |
p.D693N |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
1.00000E-10 |
- |
1.00000E-10 |
- |
BRCA1_00004 |
11 |
c.2082C>A |
2201C>A |
p.S694R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.067279157 |
- |
0.83216922 |
- |
BRCA1_00286 |
11 |
c.2083G>T |
2202G>T |
p.D695N |
0.000263283 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.009626799 |
1.340451569 |
- |
0.012904257 |
- |
BRCA1_00631 |
11 |
c.2091C>A |
2210C>A |
p.F697L |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.872390494 |
1.033092037 |
- |
0.901259673 |
- |
BRCA1_00287 |
11 |
c.2123C>A |
2242C>A |
p.S708Y |
0.07073772 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
3.73 |
- |
- |
- |
3.73 |
- |
BRCA1_00292 |
11 |
c.2146A>G |
2265A>G |
p.S716G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.914806725 |
1.033092037 |
- |
0.945079543 |
- |
BRCA1_00295 |
11 |
c.2167A>G |
2286A>G |
p.N723D |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
13.48963 |
1.15E-09 |
- |
1.55131E-8 |
- |
BRCA1_00068 |
11 |
c.2180C>T |
2299C>T |
p.P727L |
0.000166584 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.0628 |
0.13 |
- |
- |
- |
0.008164 |
- |
BRCA1_00297 |
11 |
c.2183G>A |
2302G>A |
p.R728K |
0.002680254 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.127467244 |
1.033092037 |
- |
0.131685395 |
- |
BRCA1_00298 |
11 |
c.2207A>C (Reported 2 times) |
2326A>C |
p.E736A |
0.00962 |
2 - Likely not pathogenic or of little clinical significance |
Spearman et al. 2008 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
0.14 |
3.4 |
- |
- |
0.476 |
- |
BRCA1_00100 |
11 |
c.2222C>G |
2341C>G |
p.S741C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.687900947 |
1.033092037 |
- |
1.743757028 |
- |
BRCA1_00300 |
11 |
c.2245G>C |
2364G>C |
p.D749H |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.9472 |
- |
- |
- |
- |
0.9472 |
- |
BRCA1_00301 |
11 |
c.2245G>T |
2364G>T |
p.D749Y |
0.00845048 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.404225807 |
1.033092037 |
- |
0.417602463 |
- |
BRCA1_00302 |
11 |
c.2246A>T |
2365A>T |
p.D749V |
0.081824469 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
4.091433851 |
1.067279157 |
- |
4.366702073 |
- |
BRCA1_00303 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
11 |
c.2252T>C |
2371T>C |
p.M751T |
0.060913139 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
2.79026366 |
1.1390848 |
- |
3.178346922 |
- |
BRCA1_00304 |
11 |
c.2286A>T |
2405A>T |
p.R762S |
0.00990099 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.49 |
- |
- |
- |
0.49 |
- |
BRCA1_00305 |
11 |
c.2294A>G |
2413A>G |
p.E765G |
0.063045324 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
3.191474402 |
1.033092037 |
- |
3.297086792 |
- |
BRCA1_00306 |
11 |
c.2296A>G |
2415A>G |
p.S766G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.348244307 |
1.067279157 |
- |
1.438953048 |
- |
BRCA1_00307 |
11 |
c.2315T>C |
2434T>C |
p.V772A |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
9.40E-06 |
- |
9.40000E-6 |
- |
BRCA1_00024 |
11 |
c.2338C>A |
2457C>A |
p.Q780K |
0.008689579 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.415763269 |
1.033092037 |
- |
0.429521722 |
- |
BRCA1_00310 |
11 |
c.2338C>G |
2457C>G |
p.Q780E |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.766074153 |
1.067279157 |
- |
0.817614976 |
- |
BRCA1_00311 |
11 |
c.2346T>A |
2465T>A |
p.S782R |
0.005752409 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.274417782 |
1.033092037 |
- |
0.283498825 |
- |
BRCA1_00312 |
11 |
c.2351C>T |
2470C>T |
p.S784L |
7.10578E-05 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.5224 |
0.044 |
0.102497783 |
1.477978681 |
- |
0.003482078 |
- |
BRCA1_00313 |
11 |
c.2368A>G |
2487A>G |
p.T790A |
0.0085435 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.38 |
0.638868365 |
1.739254919 |
- |
0.42223888 |
- |
BRCA1_00314 |
11 |
c.2397T>A |
2516T>A |
p.N799K |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.2856 |
2.440213563 |
1.297514181 |
- |
0.904270062 |
- |
BRCA1_00315 |
11 |
c.2412G>C |
2531G>C |
p.Q804H |
0.00045 |
1 - Not pathogenic or of no clinical significance |
Chenevix-Trench et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1.12 |
0.0087 |
- |
2.244 |
- |
0.02187 |
- |
BRCA1_00027 |
11 |
c.2416G>A |
2535G>A |
p.A806T |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.176779436 |
- |
0.917547784 |
- |
BRCA1_00316 |
11 |
c.2428A>T |
2547A>T |
p.N810Y |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.0575 |
- |
0.0038 |
5.25E-08 |
- |
1.14713E-11 |
- |
BRCA1_00069 |
11 |
c.2447A>G |
2566A>G |
p.H816R |
0.002388664 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.074377831 |
1.577415842 |
- |
0.117324769 |
- |
BRCA1_00317 |
11 |
c.2452T>G |
2571T>G |
p.C818G |
0.009418329 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.450962699 |
1.033092037 |
- |
0.465885974 |
- |
BRCA1_00318 |
11 |
c.2458A>G |
2577A>G |
p.K820E |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
<1e-10 |
- |
<1e-10 |
- |
BRCA1_00005 |
11 |
c.2473G>T |
2592G>T |
p.D825Y |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.19292906 |
1.297514181 |
- |
1.547842373 |
- |
BRCA1_00319 |
11 |
c.2477C>A |
2596C>A |
p.T826K |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Spurdle et al. 2008 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.4985 |
1 |
- |
0.0000002 |
- |
9.97000E-8 |
- |
BRCA1_00034 |
11 |
c.2482G>A |
2601G>A |
p.G828S |
0.001157899 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.051517266 |
1.102597599 |
- |
0.056802814 |
- |
BRCA1_00320 |
11 |
c.2503C>T |
2622C>T |
p.H835D |
0.006338851 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.274417782 |
1.1390848 |
- |
0.312585124 |
- |
BRCA1_00641 |
11 |
c.2518A>T |
2637A>T |
p.S840C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
4.13 |
0.452648414 |
1.067279157 |
- |
1.995212162 |
- |
BRCA1_00322 |
11 |
c.2521C>T |
2640C>T |
p.R841W |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Goldgar et al. 2004 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
4.00E-09 |
- |
- |
0.028 |
- |
1.12000E-10 |
- |
BRCA1_00003 |
11 |
c.2522G>A |
2641G>A |
p.R841Q |
0.002653803 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.5054 |
3.547345256 |
0.043197225 |
1.68354305 |
- |
0.13038234 |
- |
BRCA1_00643 |
11 |
c.2525A>G |
2644A>G |
p.E842G |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.0603 |
0.00347 |
- |
0.00021 |
- |
BRCA1_00070 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
11 |
c.2564A>C |
2683A>C |
p.Q855P |
0.008496979 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.0498 |
0.4 |
- |
- |
- |
0.41992 |
- |
BRCA1_00324 |
11 |
c.2566T>C |
2685T>C |
p.Y856H |
0.00018 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
8.80E-03 |
- |
0.0088 |
- |
BRCA1_00006 |
11 |
c.2584A>G |
2703A>G |
p.K862E |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.269 |
- |
0.00117 |
1.55 |
- |
0.00049 |
- |
BRCA1_00071 |
11 |
c.2590T>G |
2709T>G |
p.S864A |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.537367872 |
1.033092037 |
- |
0.555150469 |
- |
BRCA1_00325 |
11 |
c.2591C>T |
2710C>T |
p.S864L |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.638868365 |
1.033092037 |
- |
0.660009821 |
- |
BRCA1_00326 |
11 |
c.2596C>T |
2715C>T |
p.R866C |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.00234 |
- |
2.00E-08 |
0.0174 |
- |
8.14320E-13 |
- |
BRCA1_00072 |
11 |
c.2597G>A |
2716G>A |
p.R866H |
0.000573601 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.023897916 |
1.176779436 |
- |
0.028122576 |
- |
BRCA1_00645 |
11 |
c.2612C>A |
2731C>A |
p.P871Q |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.537367872 |
1.067279157 |
- |
0.573521529 |
- |
BRCA1_00329 |
11 |
c.2612C>G |
2731C>G |
p.P871R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.818002292 |
1.102597599 |
- |
0.901927364 |
- |
BRCA1_00330 |
11 |
c.2612C>T |
2731C>T |
p.P871L |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.02 |
0.00 |
0.02 |
- |
- |
- |
<1e-10 |
- |
<1e-10 |
- |
BRCA1_00007 |
11 |
c.2650A>G |
2769A>G |
p.T884A |
0.001399866 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.066489318 |
1.033092037 |
- |
0.068689585 |
- |
BRCA1_00331 |
11 |
c.2662C>T |
2781C>T |
p.H888Y |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
25.61114357 |
0.06100482 |
1.176779436 |
- |
1.838603965 |
- |
BRCA1_00332 |
11 |
c.2668G>C |
2787G>C |
p.G890R |
0.005555245 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.24825704 |
1.102597599 |
- |
0.273727617 |
- |
BRCA1_00333 |
11 |
c.2669G>T |
2788G>T |
p.G890V |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.02 |
0.00 |
0.02 |
1 |
- |
0.00014 |
1.45 |
- |
0.0002 |
- |
BRCA1_00073 |
11 |
c.2677A>C |
2796A>C |
p.K893Q |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.822177029 |
1.033092037 |
- |
0.849384542 |
- |
BRCA1_00334 |
11 |
c.2692A>G |
2811A>G |
p.K898E |
0.002267439 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.107790014 |
1.033092037 |
- |
0.111357005 |
- |
BRCA1_00336 |
11 |
c.2726A>T |
2845A>T |
p.N909I |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.700020165 |
1.176779436 |
- |
0.823769335 |
- |
BRCA1_00337 |
11 |
c.2728C>G |
2847C>G |
p.Q910E |
0.002342184 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.111351606 |
1.033092037 |
- |
0.115036457 |
- |
BRCA1_00338 |
11 |
c.2758G>A |
2877G>A |
p.V920I |
0.000285122 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.1637 |
- |
0.070221117 |
1.215721465 |
- |
0.013974958 |
- |
BRCA1_00339 |
11 |
c.2759T>C |
2878T>C |
p.V920A |
0.000 |
1 - Not pathogenic or of no clinical significance |
Whiley et al., 2014 |
Tavtigian et al. 2008 |
0.02 |
0.02 |
0.00 |
0.02 |
2.00E-03 |
- |
- |
- |
- |
2.00E-03 |
- |
BRCA1_00035 |
11 |
c.2765C>G |
2884C>G |
p.T922R |
0.005694054 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.9 |
0.29213061 |
1.067279157 |
- |
0.28060642 |
- |
BRCA1_00340 |
11 |
c.2770A>G |
2889A>G |
p.N924D |
0.00990099 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.49 |
- |
- |
- |
0.49 |
- |
BRCA1_00341 |
11 |
c.2773A>C |
2892A>C |
p.I925L |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.0389 |
0.00407 |
- |
0.00016 |
- |
BRCA1_00074 |
11 |
c.2783G>A |
2902G>A |
p.G928D |
0.002419504 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.111351606 |
1.067279157 |
- |
0.118843248 |
- |
BRCA1_00649 |
11 |
c.2789C>T |
2908C>T |
p.P930L |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.601872138 |
1.033092037 |
- |
0.621789314 |
- |
BRCA1_00343 |